Literature DB >> 6351898

Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely.

D M Jenkins, M O'Neill, M Mattar, V M France, B L Hsi, W P Faulk.   

Abstract

Amniochorion obtained at caesarean section and vaginal delivery, at 34-36 weeks gestation and at term, have been studied by electron microscopy and immunofluorescence for evidence of amniotic epithelial degenerative changes and the presence of plasminogen. When delivery was by caesarean section between 34-36 weeks, electron microscopy revealed no degenerative changes in four cases, but in two cases they were widespread. All but one membrane obtained at term showed only minimal amniotic epithelial cell degenerative changes, but extensive change was seen when delivery was premature after premature membrane rupture. Plasminogen was seen in amniotic epithelium proportional to the degree of cell degeneration; it was absent from healthy membranes. These findings demonstrate that degenerative changes are extensively present in membranes that rupture prematurely, particularly before the onset of premature labour, and suggest a role for plasminogen in membrane rupture.

Mesh:

Substances:

Year:  1983        PMID: 6351898     DOI: 10.1111/j.1471-0528.1983.tb09325.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  3 in total

1.  Class I antigens of the major histocompatibility complex on cytotrophoblast of human chorion laeve.

Authors:  B L Hsi; C J Yeh; W P Faulk
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

2.  Plasminogen inhibits TNFalpha-induced apoptosis in monocytes.

Authors:  Jennifer W Mitchell; Nagyung Baik; Francis J Castellino; Lindsey A Miles
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

3.  Retinoids regulate human amniotic tissue-type plasminogen activator gene by a two-step mechanism.

Authors:  Valerie Borel; Geoffroy Marceau; Denis Gallot; Loïc Blanchon; Vincent Sapin
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.